Stealth BioTherapeutics Secures Grant for Mitochondrial Disease Research Breakthrough Stealth BioTherapeutics has received a significant grant from the MRC Business Engagement Fund for pioneering research into mitochondrial disease treatments via SBT-589.

Stealth BioTherapeutics Secures Grant for Mitochondrial Disease Research Breakthrough #United_Kingdom #Stealth_BioTherapeutics #Mitochondrial_Disease #Needham,_Massachusetts #SBT-589

It was a great pleasure to be invited to the @mymitomission.bsky.social annual meet-up this past weekend. A wonderful community trying to make things better for #mitochondrial_disease. I took part in a panel discussion, did an interview, did some #mitochondria origami and had lots of fun 🤩

Khondrion Advances Innovative Therapy for Mitochondrial Disease with €5 Million Support Khondrion receives €5 million from the Dutch government plus private investments to fund Phase 3 clinical trials for mitochondrial disease treatments.

Khondrion Advances Innovative Therapy for Mitochondrial Disease with €5 Million Support #Netherlands #Nijmegen #Khondrion #Mitochondrial_Disease #Sonlicromanol